Upload others
View 2
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Addex Pharmaceuticals Investor Presentation April 2010
Addex Pharmaceuticals Investor Presentation June 2010
Investor Day - Genomic Vision › ... › Genomic-Vision-Investor... · Erwan Martin, MBA CFO • Previously with Cytomics Pharmaceuticals (CFO) and Syndex (French audit company)
Addex Pharmaceuticals Investor Presentation February 2010
TRACON PHARMACEUTICALS Investor Presentation
Addex Pharmaceuticals Investor Presentation July 2010
Access Pharmaceuticals, Inc. Investor Presentation
DISHMAN PHARMACEUTICALS & CHEMICALS LIMITED Q1 … · DISHMAN PHARMACEUTICALS & CHEMICALS LIMITED Q1 FY15 QUARTERLY INVESTOR ... Q1 FY15 RESULTS BUSINESSWISE ANALYSIS ... Process
Addex Pharmaceuticals Investor Relations Presentation December 2009
Australian Public Assessment Report for Diltiazem … · Web viewAustralian Public Assessment Report for Diltiazem hydrochloride Proprietary Product Name: Ano-Cream Sponsor: AFT Pharmaceuticals
INVESTOR UPDATEaarti-industries.com/media/investors/presentations/...•Leading manufacturer of Speciality Chemicals & Pharmaceuticals with diversified end-uses in Pharmaceuticals,
FINANCIAL REPORT 2008 - TAJ PHARMACEUTICALS GROUP...Taj Pharmaceuticals Limited (the "Company") believes that the information included in the Investor Relations section of this website
INVESTOR PRESENTATION NOVEMBER 2019 · INVESTOR PRESENTATION NOVEMBER 2019. Important Notice. 2. This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to
ACTELION’S CARDIOVASCULAR PIPELINE INVESTOR WEBCAST · © 2016 Actelion Pharmaceuticals Ltd PULMONARY AND SYSTEMIC CIRCULATION PATHWAYS 4 07 Nov 2016 Investor webcast
Addex Pharmaceuticals Investor Presentation October 2010
Investor Presentation May 7, 2013 ISIS PHARMACEUTICALS
Biostar Nasdaq: BSPM Pharmaceuticals,Inc. Investor Presentation Aug 2014
GW Pharmaceuticals Investor Presentation
Symposium Investor Roadshow November 2015 - MGC Pharmaceuticals
AFT PHARMACEUTICALS · Investor Presentation May 2016 1 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general overview
IOL Chemicals and Pharmaceuticals Limited Investor ... Presentation - IOL_16...2021/02/16 · About IOL Chemicals and Pharmaceuticals Limited Incorporated in 1986, IOLCP is one of
AFT PHARMACEUTICALS LIMITED Annual Report 2017 · Australia New Zealand Rest of World Southeast Asia AFT at a glance OVERALL REVENUE GREW 8% WITH AUSTRALIA, OUR LARGEST MARKET, GROWING
Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical
AFT PHARMACEUTICALS - ASX · June 2016. 5. ACCELERATING CLINICAL STUDY PROGRAM • 12 studies across the AFT portfolio • 1500+ patients • 7 countries - Australia, Jordan, Mexico,
IMPRIMIS PHARMACEUTICALS NASDAQ: IMMYfilecache.drivetheweb.com/ir1_imprimis/177/download/IMMY-Investor... · IMPRIMIS PHARMACEUTICALS NASDAQ: IMMY ... actual results could vary materially
Investor Day - Alexion Pharmaceuticals, Inc
Addex Pharmaceuticals Investor Relations Presentation October 2009
NovaBay Pharmaceuticals Investor Presentation November 2020
INVESTOR PRESENTATION MAY 2019INVESTOR PRESENTATION MAY 2019 Important Notice 2 This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general